These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27703374)

  • 1. Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer.
    Wang X; Teng F; Kong L; Yu J
    Onco Targets Ther; 2016; 9():5761-5770. PubMed ID: 27703374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy.
    Kutlu Y; Aydin SG; Bilici A; Oven BB; Olmez OF; Acikgoz O; Hamdard J
    Medicine (Baltimore); 2023 Apr; 102(15):e33432. PubMed ID: 37058061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
    Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH
    Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer.
    Wang H; Ding Y; Li N; Wu L; Gao Y; Xiao C; Jiang H; Zheng Y; Mao C; Deng J; Wang H; Xu N
    Front Oncol; 2020; 10():841. PubMed ID: 32637353
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
    Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.
    Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB
    Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Yılmaz U; Ozdemir O; Batum O; Ermin S
    Indian J Cancer; 2018; 55(3):276-281. PubMed ID: 30693894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer.
    Kang MH; Go SI; Song HN; Lee A; Kim SH; Kang JH; Jeong BK; Kang KM; Ling H; Lee GW
    Br J Cancer; 2014 Jul; 111(3):452-60. PubMed ID: 24921916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
    Solmaz S; Uzun O; Acar C; Sevindik OG; Piskin O; Ozsan HG; Demirkan F; Undar B; Alacacioglu A; Ozcan MA; Alacacioglu I
    J Lab Physicians; 2018; 10(4):363-369. PubMed ID: 30498304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy.
    Xia WY; Zhu XR; Feng W; Liu J; Wang JM; Lv CX; Zhang Q; Yu W; Cai XW; Fu XL
    Transl Lung Cancer Res; 2020 Oct; 9(5):1996-2007. PubMed ID: 33209619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy.
    D'Emic N; Engelman A; Molitoris J; Hanlon A; Sharma NK; Moeslein FM; Chuong MD
    J Gastrointest Oncol; 2016 Apr; 7(2):269-77. PubMed ID: 27034796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.
    Hyder J; Boggs DH; Hanna A; Suntharalingam M; Chuong MD
    J Gastrointest Oncol; 2016 Apr; 7(2):189-95. PubMed ID: 27034785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total lymphocyte count, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as prognostic factors in advanced non-small cell lung cancer with chemoradiotherapy.
    Song X; Chen D; Yuan M; Wang H; Wang Z
    Cancer Manag Res; 2018; 10():6677-6683. PubMed ID: 30584362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.